#WhoWeAre Cyclo Therapeutics is built on a deep commitment to those affected by rare and serious diseases. Supporting patients, families and caregivers is at the heart of everything we do. $RFL #RareDisease

#DidYouKnow #NiemannPick disease is a #RareDisease, affecting fewer than 9,000 people worldwide. Join us this #RareDiseaseDay on February 28 to support the Niemann-Pick community and help raise awareness. $RFL #NiemannPick #NPC1

Sign up for alerts to stay informed on our latest updates. At Cyclo, we are working to make a difference for individuals and families living with #NiemannPick. bit.ly/44RHGgU $RFL #RareDisease

Honored to attend the Firefly Fund Dreams Gala 2026 and support Firefly’s mission in service of the rare disease community. An inspiring evening alongside others committed to advancing care and improving the lives of patients and families. $RFL #NPC1 #NiemannPick #RareDisease

After ten years as CEO, we share this with deep gratitude for Scott’s leadership and service to the NPC community. Inspired by his late wife, Cathy, whose kindness and strength shaped a mission that uplifted so many, Scott made a lasting impact. vimeo.com/1165699924/d5a6988…

Our team is live @WORLDSymposia! It’s inspiring to engage with advocacy groups and trial investigators, all united by a shared mission to advance Niemann-Pick disease research. Together, we’re pushing progress forward. @NNPDF @inpda_org @inpda_org @inpdr_registry @NiemannPickUK

Stop by our poster presentation today, from 3:30–5:30 PM PST at #WORLDSymposium 2026: Intravenous hydroxypropyl-beta-cyclodextrin (HPBCD): Biomarkers, efficacy, and impact of dosing and administration route on therapeutic index $RFL #NPC1 #NiemannPick #RareDisease

Happening today at #WORLDSymposium 2026 📍 We will be presenting three posters this afternoon from 3:30–5:30 PM PST. Don’t miss the opportunity to stop by, learn more, and connect with our team. $RFL #WORLDSymposium #RareDisease #NiemannPick #NPC1 #LysosomalStorageDisorders

Our team will be on site at the 2026 #WORLDSymposium, presenting three posters on Thursday, February 5, from 3:30–5:30 PM PST, and connecting with the rare disease community. Find our schedule and presentation times here: bit.ly/48WFver #WORLDSymposium $RFL

We’re in San Diego for #WORLDSymposium, February 2–6, connecting with the Niemann-Pick disease community and engaging in important discussions on lysosomal storage disorders. For those interested in meeting with our team, reach out to [email protected]. @WORLDSymposia

We are excited to be presenting at the 22nd Annual #WORLDSymposium, taking place February 2-6, 2026, in San Diego, CA. If you’ll be attending and would like to connect, we’d love to hear from you. Please reach out to [email protected]. $RFL @WORLDSymposia #NiemannPick

#DidYouKnow: Our TransportNPC™ trial is the most comprehensive pivotal study ever conducted for Niemann-Pick Disease Type C1, spanning global reach, diverse patient participation and meaningful clinical outcomes. $RFL #NiemannPick #NPC1

We’re united by a shared purpose, to raise awareness and improve the lives of patients, families and caregivers impacted by rare and serious diseases. Our commitment is unwavering, and the progress we’re making is real. $RFL #NiemannPick #NPC1

At Cyclo Therapeutics, our mission is driven by compassion and purpose. We stand with patients, families and caregivers affected by rare and serious diseases, working every day to bring hope, progress and meaningful change. $RFL #NiemannPick #NPC1

November is National Alzheimer’s Disease Awareness Month, a time to learn, share, and stand together in support of those affected. Join us as we raise awareness and advocate for progress in Alzheimer’s research and care. @alzassociation #AlzheimersAwareness #EndAlzheimers

This #NiemannPickAwarenessMonth, learn how patient registries drive research and improve lives. Visit bit.ly/3Yfo8Dk to get involved. $RFL #NiemannPick #NPC1 @inpdr_registry

#DidYouKnow: Niemann-Pick Disease Type C is a rare, progressive, and fatal genetic disorder. A defect in the NPC1 protein causes cholesterol and lipids to build up in cells, leading to organ dysfunction and cell death. $RFL #NiemannPick #NPC1 #RareDiseaseAwareness

Our Medical Science Liaison, Joseph Mejia, is in Argentina supporting #NiemannPickDiseaseAwarenessDay and joining the global community in raising awareness for patients and families impacted by this rare disease. $RFL #NiemannPick #RareDisease #NiemannPickAwareness @INDPA_org

Niemann-Pick Disease impacts ~1 in 100,000 people, with about 35 new U.S. cases each year. Learn more about #NPC1: bit.ly/44t6U5P $RFL #NiemannPick #NPC1